Nepafenac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0J9L7J6V8C, chemically known as benzeneacetamide, 2-amino-3-benzoyl- but generally known as nepafenac, which bears US NIH Compound Identifier 151075. European Medicines Agency schedules Nepafenac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09197MIG. The term NEPAFENAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules nepafenac in its Anatomical Therapeutic Chemical (ATC) Classification. NEPAFENAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nepafenac under HS 29242995 and SITC 51479. As of Q4 2014, NEPAFENAC remains the US FDA Preferred Term for this commodity. Nepafenac bears US NLM identifiers UMLS ID C0961209 and NCI Concept Code C66228. SMILES: O=C(C1C(N)C(CC(=O)N)CCC1)C1CCCCC1.